SARAH GREGORY: Open Payments
NPI 1881060002 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,242 in 64 payments from 13 companies in 2025. Trend: 2023 $4,053 · 2024 $922 · 2025 $1,242
Food & beverage: $1,242
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $203 |
| Amgen Inc. | 8 | $178 |
| Novo Nordisk Inc | 6 | $167 |
| Boston Scientific Corporation | 4 | $109 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $92 |
| Merck Sharp & Dohme LLC | 4 | $83 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $75 |
| SCPHARMACEUTICALS INC. | 3 | $65 |
Products named: LEQVIO, REPATHA, Ozempic, WATCHMAN FLX, Kerendia, LifeVest, JARDIANCE, FUROSCIX.
Industry payments across TN — which companies pay providers there.
